The program aims promote medical research into the discovery of better treatments for diabetes.

The program aims promote medical research into the discovery of better treatments for diabetes, facilitating cooperation between the pharmaceutical industry and universities have the potential provide make drug targets and lead products.

The Centers for Disease Control and Prevention , the Agency for Healthcare Research and Quality , the National Institutes of Health and the Food and Drug Administration will be present at the meeting along with representatives of more than eight companies to develop therapies for various autoimmune and rheumatic diseases. Also present representatives from overseas regulatory authorities and the leaders of the pediatric rheumatology networks both in the United States and Pediatric Rheumatology Pediatric Rheumatology International Trials Organization) be.. Continue reading “The program aims promote medical research into the discovery of better treatments for diabetes.”